Therapeutic Effects of Hippotherapy in Children With Prader-Willi Syndrome
NCT ID: NCT03858023
Last Updated: 2019-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2016-08-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Hippotherapy on Physical Fitness and Attention in Cerebral Palsy
NCT03870893
Effect of Vibration Therapy on Hip Girdle Muscles in Healthy People
NCT05831904
Therapeutic Effects of Constraint-Induced Movement Therapy on Young Children With Cerebral Palsy
NCT03858335
Virtual Reality vs Functional Strength Training in Children With Cerebral Palsy
NCT05494905
Development of a Remote Therapy Protocol for Upper Limb Function Enhancement in Children With Cerebral Palsy
NCT06272760
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary purpose of this study is to investigate effect of hippotherapy on motor function of Prader-Willi syndrome patients.
The secondary purpose is to compare motor function, obesity, and behavior of the children after the intervention with those parameters before the intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hippotherapy
Children in hippotherapy arm will participate in hippotherapy (30 min/sessions, twice a week, 15 weeks)
Hippotherapy
The hippotherapy program consists of 2 sessions per week for 15 weeks. One session is 30-minute session. The program involves 2 therapists and 3 personnel for safety issues.
Control
Children in control group will not receive hippotherapy
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hippotherapy
The hippotherapy program consists of 2 sessions per week for 15 weeks. One session is 30-minute session. The program involves 2 therapists and 3 personnel for safety issues.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* can follow one step command
Exclusion Criteria
* serious medical conditions such as cardiac disease, pulmonary disease, uncontrolled epilepsy
* visual impairment, hearing impairment
* bleeding tendency, anticoagulation
* fracture within 6 months, major orthopedic surgery within 1 year
42 Months
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Samsung Electronics
INDUSTRY
Samsung Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jeong Yi Kwon
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
JEONG-YI KWON, MD, PHD
Role: PRINCIPAL_INVESTIGATOR
Samsung Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Samsung Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-07-058-005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.